Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy episode artwork

EPISODE · Mar 30, 2020 · 3 MIN

Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

from MS News & Perspectives · host MS News Today

MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy.Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/

Episode metadata supplied by the publisher feed · Published Mar 30, 2020

Embed this episode

NOW PLAYING

Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy

0:00 3:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 3 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on March 30, 2020.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!